BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1516845)

  • 1. Antioxidant activity of ubiquinone-3 in human low density lipoprotein.
    Merati G; Pasquali P; Vergani C; Landi L
    Free Radic Res Commun; 1992; 16(1):11-7. PubMed ID: 1516845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper ions promote peroxidation of low density lipoprotein lipid by binding to histidine residues of apolipoprotein B100, but they are reduced at other sites on LDL.
    Wagner P; Heinecke JW
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3338-46. PubMed ID: 9409331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation.
    Barnhart RL; Busch SJ; Jackson RL
    J Lipid Res; 1989 Nov; 30(11):1703-10. PubMed ID: 2614272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteolin-rich artichoke extract protects low density lipoprotein from oxidation in vitro.
    Brown JE; Rice-Evans CA
    Free Radic Res; 1998 Sep; 29(3):247-55. PubMed ID: 9802556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-oxidative modification of native low-density lipoprotein by oxidized low-density lipoprotein.
    Yang M; Leake DS; Rice-Evans CA
    Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):377-80. PubMed ID: 8687375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein oxidation in the absence of lipid peroxidation enhances LDL uptake by macrophages.
    Hunt JV; Bailey JR; Schultz DL; McKay AG; Mitchinson MJ
    FEBS Lett; 1994 Aug; 349(3):375-9. PubMed ID: 8050600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach.
    Kontush A; Hübner C; Finckh B; Kohlschütter A; Beisiegel U
    Free Radic Res; 1996 Feb; 24(2):135-47. PubMed ID: 8845914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of plasma low density lipoprotein to cupric ion-induced peroxidation in patients with variant angina.
    Miwa K; Miyagi Y; Fujita M
    J Am Coll Cardiol; 1995 Sep; 26(3):632-8. PubMed ID: 7642852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant activity of aminoethylcysteine ketimine decarboxylated dimer on copper-induced LDL oxidation.
    Matarese RM; Macone A; Fontana M; Duprè S; Cavallini D
    Biochem Mol Biol Int; 1998 Nov; 46(4):829-37. PubMed ID: 9844744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro low-density lipoprotein oxidation by copper or *OH/O*(2)(-): new features on carbonylation and fragmentation of apolipoprotein B during the lag phase.
    Zarev S; Bonnefont-Rousselot D; Cosson C; Beaudeux JL; Delattre J; Gardès-Albert M; Legrand A; Thérond P
    Arch Biochem Biophys; 2002 Aug; 404(1):10-7. PubMed ID: 12127064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin inhibits oxidative modification of human low-density lipoprotein.
    Kelly MR; Loo G
    J Pineal Res; 1997 May; 22(4):203-9. PubMed ID: 9247205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mangostin inhibits the oxidative modification of human low density lipoprotein.
    Williams P; Ongsakul M; Proudfoot J; Croft K; Beilin L
    Free Radic Res; 1995 Aug; 23(2):175-84. PubMed ID: 7581813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin protects LDL from oxidation but does not prevent the apolipoprotein derivatization.
    Pieri C; Marra M; Gáspár R; Damjanovich S
    Biochem Biophys Res Commun; 1996 May; 222(2):256-60. PubMed ID: 8670192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation.
    Belinky PA; Aviram M; Fuhrman B; Rosenblat M; Vaya J
    Atherosclerosis; 1998 Mar; 137(1):49-61. PubMed ID: 9568736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydrobiopterin inhibits copper-induced oxidation of low density lipoprotein.
    Sakuma S; Fujimoto Y; Gohda Y; Fujita T
    Res Commun Mol Pathol Pharmacol; 2000; 107(5-6):397-406. PubMed ID: 11589366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetravalent vanadium mediated oxidation of low density lipoprotein.
    Dickson C; Stern A
    Int J Biochem; 1990; 22(5):501-6. PubMed ID: 2112099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid hormone (T3) and its acetic derivative (TA3) protect low-density lipoproteins from oxidation by different mechanisms.
    Faure P; Oziol L; Artur Y; Chomard P
    Biochimie; 2004 Jun; 86(6):411-8. PubMed ID: 15283976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid.
    Bagnati M; Perugini C; Cau C; Bordone R; Albano E; Bellomo G
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):143-52. PubMed ID: 10229669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of magnoflorine isolated from coptidis rhizoma on Cu2+-induced oxidation of human low density lipoprotein.
    Hung TM; Na M; Min BS; Zhang X; Lee I; Ngoc TM; Thuong PT; Sok DE; Bae K
    Planta Med; 2007 Oct; 73(12):1281-4. PubMed ID: 17973202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.